Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Director/PDMR Shareholding

25 Jun 2020 10:20

RNS Number : 0783R
Scapa Group PLC
25 June 2020
 

25 June 2020

LEI No. 213800QIPVTK5ES5UU36

 

SCAPA GROUP PLC

('the Company')

 

Director/PDMR Shareholding

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities ('PDMR')

 

Scapa Group plc (AIM: SCPA) announces that it was notified on 24 June 2020 that Mr Heejae Chae, Group Chief Executive of the Company, purchased 19,899 Ordinary shares in the Company on 24 June 2020 at a price of 100.0 pence per share. Mr Chae's beneficial holding in the Company following the purchase is as follows:

 

Director/Person CloselyAssociated

No. of Ordinary Shares held prior to Purchase

No. of Ordinary Shares Purchased

No. of Ordinary Shares held following Purchase

Percentage of Issued Share Capital following Purchase

Heejae Chae

1,124,324

19,899

1,144,223

0.61%

 

Mr Chae also has a beneficial interest in respect of 1,645,766 (1.06%) Ordinary Shares, under the Scapa Group plc 2015 Value Creation Plan and 152,613 Ordinary Shares (0.10%) under the Scapa Group plc 2011 Performance Share Plan. These shares have vested and will be released to Mr Chae upon exercise pursuant to the respective plan rules.

 

The notification below, made in accordance with the requirements of Article 19 of the Market Abuse Regulation, provides further detail.

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Heejae Chae

 

2

Reason for the notification

 

a)

Position / status

Group Chief Executive

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Scapa Group plc

 

b)

LEI

 

213800QIPVTK5ES5UU36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 

a)

Description of financial instrument,

type of instrument

Ordinary Shares of 5p each

 

Identification Code

 

GB0007281198

b)

Nature of the transaction

Purchase of shares

 

c)

Price(s) and volume(s)

 

Purchase of 19,899 shares at 100p per share

d)

Aggregated information

- Aggregated volume

- Price

Volume: 19,899 ordinary shares of 5p each, purchase price of 100 pence per share

Aggregated: £19,899

 

e)

Date of the transaction

 

24 June 2020

f)

Place of the transaction

 

London Stock Exchange, AIM

 

For further information:

 

Scapa Group plc:

Wendy Baker

Company Secretary

+44 (0) 161 301 7400

Numis Securities Limited:

Mark Lander/ Freddie Barnfield / Duncan Monteith

(Joint Broker/Nominated Adviser)

+44 (0) 20 7260 1000

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUVAKRRWUNURR
Date   Source Headline
1st Dec 201510:11 amRNSHolding(s) in Company
1st Dec 201510:10 amRNSHolding(s) in Company
30th Nov 201510:34 amRNSTotal Voting Rights
24th Nov 20157:00 amRNSInterim Results
3rd Nov 20154:55 pmRNSHolding(s) in Company
3rd Nov 20154:54 pmRNSShareholder Circular Posted
13th Oct 20157:00 amRNSTrading Statement
10th Sep 20151:03 pmRNSAdditional Listing
9th Sep 20159:48 amRNSHolding(s) in Company
1st Sep 20153:57 pmRNSBlocklisting Interim Review
1st Sep 20153:29 pmRNSAdditional Listing
11th Aug 20151:28 pmRNSAdditional Listing
10th Aug 20159:46 amRNSDirector/PDMR Shareholding
23rd Jul 20159:21 amRNSDirector/PDMR Shareholding
21st Jul 20157:00 amRNSAGM Statement
14th Jul 20153:56 pmRNSAdditional Listing
13th Jul 20151:26 pmRNSHolding(s) in Company
2nd Jul 201511:15 amRNSAdditional Listing
17th Jun 20157:00 amRNSHealthcare Site Visit
16th Jun 20159:15 amRNSAdditional Listing
10th Jun 20152:54 pmRNSHolding(s) in Company
5th Jun 20159:01 amRNSHolding(s) in Company
4th Jun 20159:31 amRNSHolding(s) in Company
3rd Jun 20158:59 amRNSHolding(s) in Company
27th May 20157:00 amRNSFinal Results
28th Apr 20153:27 pmRNSAdditional Listing
9th Apr 20157:00 amRNSTrading Statement
7th Apr 20154:38 pmRNSHolding(s) in Company
7th Apr 20153:43 pmRNSAdditional Listing
31st Mar 20159:12 amRNSTotal Voting Rights
30th Mar 20154:02 pmRNSAdditional Listing
30th Mar 20152:58 pmRNSDirector/PDMR Shareholding
18th Mar 20154:45 pmRNSHolding(s) in Company
16th Mar 20154:20 pmRNSAdditional Listing
10th Mar 20154:10 pmRNSAdditional Listing
9th Mar 20157:00 amRNSHolding(s) in Company
5th Mar 20157:00 amRNSDirector/PDMR Shareholding
5th Mar 20157:00 amRNSDirector/PDMR Shareholding
4th Mar 20157:00 amRNSDirector/PDMR Shareholding
2nd Mar 20153:58 pmRNSAdditional Listing
2nd Mar 20157:00 amRNSAcquisition
23rd Feb 20159:08 amRNSHolding(s) in Company
16th Feb 20159:01 amRNSHolding(s) in Company
13th Feb 20159:09 amRNSHolding(s) in Company
11th Feb 201510:52 amRNSHolding(s) in Company
9th Feb 20151:35 pmRNSHolding(s) in Company
9th Feb 201510:33 amRNSBlocklisting Interim Review
4th Feb 201512:18 pmRNSHolding(s) in Company
23rd Jan 20159:59 amRNSHolding(s) in Company
31st Dec 201412:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.